Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial - Oldgren, J; Alings, M; Darius, H; on behalf of the RE-LY Investigators (Ann Intern Med, 2011)